Monday - July 27, 2026
Paul Hastings Advises Barclays, BTIG and Titan Partners on Humacyte's Public Offering
June 15, 2026
LOS ANGELES, California, June 15 [Category: BizLaw/Legal] -- Paul Hastings, a law firm, issued the following news:

* * *

Paul Hastings Advises Barclays, BTIG and Titan Partners on Humacyte's Public Offering

*

Paul Hastings LLP advised Barclays, BTIG and Titan Partners as joint bookrunning managers for Humacyte Inc.'s (Nasdaq: HUMA) $50 million public offering of 47,619,048 shares of its common stock at a price of $1.05 per share. In a . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products